- United States
- /
- Semiconductors
- /
- NasdaqGS:FORM
FormFactor (FORM) Stock Could Be 38% Overvalued After AI Driven Analyst Upgrades
FormFactor (FORM) stock has been in focus after recent analyst upgrades related to its exposure to artificial intelligence and high bandwidth memory, along with higher earnings estimates and a top Zacks Rank.
See our latest analysis for FormFactor.
FormFactor’s recent analyst upgrades and AI related enthusiasm come on top of strong momentum, with a 7 day share price return of 20.84% and a 1 year total shareholder return of 320.40% that hint at a sharp shift in sentiment around the stock’s growth and risk profile.
If you are looking for other ways to position around AI hardware and testing themes, it could be worth scanning the 49 AI infrastructure stocks
The rally in FormFactor stock and fresh AI optimism now meet a very different question: with shares near analyst targets and some valuation tools flagging it as expensive, is there still a window for opportunity, or is future growth already priced in?
Most Popular Narrative: 38% Overvalued
FormFactor is trading at $139.95 against a most followed fair value estimate of $101.56, so the current price leans well ahead of that narrative.
Accelerating adoption of generative AI, high-performance computing, and HBM DRAM in data centers is driving substantial increases in test complexity and intensity. FormFactor's differentiated probe cards and early leadership in HBM4 chiplet testing position the company to benefit from higher ASPs and revenue growth as these markets scale. (Impacts: Revenue, potential margin improvement)
Curious what kind of revenue runway, margin lift and future earnings multiple would need to line up to support that fair value math at FormFactor stock?
Result: Fair Value of $101.56 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, FormFactor’s story can change quickly if DRAM and HBM demand swings, or if higher operating costs and tariffs keep pressure on margins and cash generation.
Find out about the key risks to this FormFactor narrative.
Next Steps
If the FormFactor story so far feels mixed to you, that is exactly the point. Weigh the concerns against the potential and review the 2 key rewards and 3 important warning signs.
Looking for more investment ideas beyond FormFactor stock?
If FormFactor has caught your attention, do not stop there. Broaden your watchlist with other focused ideas that could better match your goals and risk comfort.
- Target potential mispricing by scanning companies that look cheaper than their fundamentals suggest through the 48 high quality undervalued stocks.
- Strengthen your income stream by reviewing stocks that feature resilient payouts and higher yields in the 8 dividend fortresses.
- Prioritize stability by checking out companies screened for lower risk profiles using the 65 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:FORM
FormFactor
Designs, manufactures, and sells probe cards, analytical probes, probe stations, thermal systems, cryogenic systems, and related services in the United States, South Korea, Taiwan, China, Japan, Singapore, Europe, Malaysia, and internationally.
Flawless balance sheet with reasonable growth potential.
Similar Companies
Market Insights
Weekly Picks

This small biotech is developing technology that could potentially change how tissue is rebuilt

The Picks-and-Shovels Leader of the Grid Supercycle
KRMN — Karman Space & Defense: Down 58% from Peak, Is the Market Mispricing a Hypergrowth Defense Compounder?

Invinity Energy Systems: All About That BESS
Recently Updated Narratives
PROCEPT BioRobotics sees 17.69% revenue growth and aims for 12.94% profit margin
UUE Holdings Trading at Deep Value Despite Strong Growth Prospects

Strategic and Financial Blueprint of Micron Technology: Resolving the Memory Wall in the Gen-AI Era
Popular Narratives

Investment Analysis (May 2026)

Adobe: A Probabilistic Case for Undervaluation

Honeywell - The Demand-Side of the AI Infrastructure
Trending Discussion
